Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Direct Filing of Hernia Mesh Lawsuits Now Permitted in Atrium C-Qur Litigation

Hernia mesh lawsuits involving Atrium Medical Corp.’s C-Qur patch are moving forward in the U.S. District Court, District of New Hampshire. According to a Case Management Order dated February 10, 2017, the Court is now permitting plaintiffs to file directly … Continue reading

Insurance Coverage Appears to Influence Rate of Shoulder Replacement Complications

Does insurance coverage influence complication rates in shoulder replacement surgery? Findings from a new study published this month in the Journal of Shoulder and Elbow Surgery suggests that it may. The study drew data from more than 100,000 shoulder replacement … Continue reading

Doctor’s Breast Implant Illness Denial Elicits Strong Response

Numerous women in Arizona have come forward with tales of “breast implant illness,” after a local plastic surgeon went on TV to insist that no such ailment exists. The saga began earlier this month, when a former Playboy model from … Continue reading

European Regulators Confirm Hep B Reactivation Risk With Direct Acting Antiviral Hepatitis C Medications

Regulators in Europe have recommended Hepatitis B screening for all patients being considered for treatment with direct acting antiviral Hepatitis C medications.  According to the European Medicines Agency’s (EMA’s) Pharmacovigilance Risk Assessment Committee (PRAC), a review has confirmed that these … Continue reading

Federal Invokana Litigation Planning for Science Day

The federal court overseeing dozens of Invokana and Invokamet lawsuits will soon delve into the scientific and medical issues at the heart of those cases. According to court documents, the parties have been directed to agree on a date for … Continue reading

Defense Verdict in Talcum Powder Lawsuit Ends Johnson & Johnson’s Losing Streak

Johnson & Johnson has been cleared of liability in the latest trial involving talcum powder and ovarian cancer. The verdict was the first win for Johnson & Johnson, which had already been assessed massive judgments in three earlier talcum powder … Continue reading

Proton Pump Inhibitors May Endanger Those with Coronary Artery Disease

Patients suffering from coronary artery disease (CAD) might want to think twice about taking proton pump inhibitors. A new study suggests that the popular heartburn drugs could  increase the risk of heart failure and death in these individuals. Many patients … Continue reading

LivNova Acts to Remediate 3T Heater-Coolers Implicated in Bacterial Infections

LivNova PLC has announced a plan to remediate 3T Heater-Coolers. The devices, which are designed to warm and cool patients undergoing cardiac thoracic surgery, have been implicated in outbreaks of M. chimaera bacterial infections at several U.S. hospitals. “The remediation … Continue reading

Johnson & Johnson SEC Filing Reveals 18,000+ Risperdal Lawsuits

The products liability litigation involving Risperdal shows no signs of slowing down. In a recent filing with the U.S. Securities and Exchange Commission (SEC), Johnson & Johnson acknowledged that the litigation continues to grow, with at least 18,500 Risperdal lawsuits … Continue reading

Closing Arguments Expected Tomorrow in Fourth Talcum Powder Trial

Missouri’s fourth talcum powder trial is nearing its end, with the parties expected to present their closing arguments tomorrow. The high-stakes trial opened on February 9th in the Missouri 22nd Judicial Circuit Court for St. Louis City, and is being … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content